FLT3 Mutations in Early T-Cell Precursor ALL Characterize a ...
journals.plos.org
— Martin Neumann · Ebru Coskun · Lars Fransecky · Liliana H. Mochmann · Isabelle Bartram · Nasrin Farhadi Sartangi · Sandra Heesch · Nicola Gökbuget. › authors
FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell...
www.scienceopen.com
Authors: Martin Neumann, Ebru Coskun, Lars Fransecky, Liliana H. Mochmann, Isabelle Bartram, Nasrin Farhadi Sartangi, Sandra Heesch, ...
Overall survival and subgroup analysis from a randomized phase III...
www.scienceopen.com
Cited by 1. Outlook on PI3K/AKT/mTOR inhibition in acute leukemia. Authors: Lars Fransecky, Liliana Mochmann, Claudia Baldus · See all cited by ...
Synergistic induction of apoptosis by combination of BTK and dual...
www.scienceopen.com
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia. Authors: Lars Fransecky, Liliana Mochmann, Claudia Baldus · Cited 1 times. Previous item. Next item · See more similar articles. Build your own search ...
Articles - Molecular and Cellular Therapiesmolcelltherapies.biomedcentral.com › articles
molcelltherapies.biomedcentral.com
Authors: Lars Fransecky, Liliana H Mochmann and Claudia D Baldus. Citation: Molecular and Cellular Therapies :2. Content type: Review.
OPUS 4 | FLT3 mutations in Early T-Cell Precursor ALL characterize ...publikationen.ub.uni-frankfurt.de › year › docId
publikationen.ub.uni-frankfurt.de
· Martin Neumann, Ebru Coskun, Lars Fransecky, Liliana H. Mochmann, Isabelle Bartram, Nasrin Farhadi Sartangi, Sandra Heesch, Nicola ...
Alle Infos zum Namen "Lars Fransecky"
FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem ...plos.altmetric.com › details
plos.altmetric.com
Martin Neumann, Ebru Coskun, Lars Fransecky, Liliana H. Mochmann, Isabelle Bartram, Nasrin Farhadi Sartangi, Sandra Heesch, Nicola Gökbuget, Stefan Schwartz ...
FLT3 Mutations in Early T-Cell Precursor ALL Figshare
figshare.com
posted on , 17:10 by Martin Neumann, Ebru Coskun, Lars Fransecky, Liliana H. Mochmann, Isabelle Bartram, Nasrin Farhadi Sartangi, Sandra Heesch, ... › articles › dataset › FLT3_Mutatio...
Growth inhibition of Jurkat cells transfected with FLT3 expression...
figshare.com
T00:27:00Z (GMT) by Martin Neumann Ebru Coskun Lars Fransecky Liliana H. Mochmann Isabelle Bartram Nasrin Farhadi Sartangi Sandra Heesch ...
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia
cyberleninka.org
Similar topics of scientific paper in Clinical medicine , author of scholarly article — Lars Fransecky, Liliana H Mochmann, Claudia D Baldus. › article
Most recent papers in the journal Molecular and Cellular Therapies |...
read.qxmd.com
Lars Fransecky, Liliana H Mochmann, Claudia D Baldus. Technological advances allowing high throughput analyses across numerous cancer tissues have ...
PLOS ONE: FLT3 Mutations in Early T-Cell Precursor ALL Characterize a...
journals.plos.org
Lars Fransecky, ... Martin Neumann,; Ebru Coskun,; Lars Fransecky,; Liliana H. Mochmann,; Isabelle Bartram,; Nasrin Farhadi Sartangi,; Sandra ...
FLT3 Mutations in Early T-Cell Precursor ALL Characterize a PLOSjournals.plos.org › plosone › article › comments › j...
journals.plos.org
· Martin Neumann, · Ebru Coskun, · Lars Fransecky, · Liliana H. Mochmann, · Isabelle Bartram, · Nasrin Farhadi Sartangi, · Sandra Heesch, · Nicola ...
Neues Suchportal HLB Fulda: Intern: FLT3 mutations in Early...
hds.hebis.de
... kinase inhibitors [Elektronische Ressource] / Martin Neumann, Ebru Coskun, Lars Fransecky, Liliana H. Mochmann, Isabelle Bartram, Nasrin Farhadi Sartangi, ...
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia | Read by QxMD
read.qxmd.com
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia. Lars Fransecky, Liliana H Mochmann, Claudia D Baldus. Molecular and Cellular Therapies 2015, 3: 2.
sortiert nach Relevanz / Datum